The value of medicines from a social perspective
Differential aspects of orphan drugs and their value from a social perspective
Optimizing the involvement of EFCCA patients in medicines-related decision making
Excess mortality during the COVID-19 pandemic in Spain by non-COVID-19 causes of death
The assessment and funding processes of drugs in Spain and other OECD countries: Where are we and where are we going?
Strategic reflection on funding and access to rare disease therapies in Spain
Multi-Criteria Decision Analasys in Healthcare: its usefulness and limitations for decision making
